Citation: Ig. Levy et al., PROSTATE-CANCER - 1 - THE DESCRIPTIVE EPIDEMIOLOGY IN CANADA, CMAJ. Canadian Medical Association journal, 159(5), 1998, pp. 509-513
Authors:
LAVIS JN
LOMAS J
ANDERSON GM
DONNER A
ISCOE NA
GOLD G
CRAIGHEAD J
Citation: Jn. Lavis et al., FREESTANDING HEALTH-CARE FACILITIES - FINANCIAL ARRANGEMENTS, QUALITYASSURANCE AND A PILOT-STUDY, CMAJ. Canadian Medical Association journal, 158(3), 1998, pp. 359-363
Authors:
MERCER SL
GOEL V
LEVY IG
ASHBURY FD
IVERSON DC
ISCOE NA
Citation: Sl. Mercer et al., PROSTATE-CANCER SCREENING IN THE MIDST OF CONTROVERSY - CANADIAN MENSKNOWLEDGE, BELIEFS, UTILIZATION, AND FUTURE INTENTIONS, Canadian journal of public health, 88(5), 1997, pp. 327-332
Authors:
RUSTHOVEN JJ
QUIRT IC
ISCOE NA
MCCULLOCH PB
JAMES KW
LOHMANN RC
JENSEN J
BURDETTERADOUX S
BODURTHA AJ
SILVER HKB
VERMA S
ARMITAGE GR
ZEE B
BENNETT K
HEDLEY D
FINE S
MYERS R
KING M
MERTENS W
TAYLOR M
CANO P
MALIK S
VERGIDIS D
SHORE S
DUDGEON D
SMYLIE M
WILSON K
KNOWLING M
SAMOSH M
GIESBRECHT J
HUAN S
SKILLINGS J
GREGG R
BELANGER K
POLLAK M
LATREILLE J
BATIST G
BOOS G
GRUNER P
HINGS I
LOUTFI A
THIRLWELL M
TRUDEAU M
JOLIVIT J
AYOUB J
CHARPENTIER D
CLEMENT S
YELLE L
BELANGER D
SHIBATA H
Citation: Jj. Rusthoven et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE RESPONSE RATES OF CARMUSTINE, DACARBAZINE, AND CISPLATIN WITH AND WITHOUT TAMOXIFEN IN PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 14(7), 1996, pp. 2083-2090
Citation: Ja. Ramsay et al., MIB-1 PROLIFERATIVE ACTIVITY IS A SIGNIFICANT PROGNOSTIC FACTOR IN PRIMARY THICK CUTANEOUS MELANOMAS, Journal of investigative dermatology, 105(1), 1995, pp. 22-26
Citation: Na. Iscoe et al., INVOLVING SURGEONS IN DISCUSSIONS OF BREAST-CANCER SURGERY - REPLY, CMAJ. Canadian Medical Association journal, 151(6), 1994, pp. 734-736
Authors:
ISCOE NA
NAYLOR CD
WILLIAMS JI
DEBOER G
MORGAN MW
FEHRINGER G
HOLOWATY E
Citation: Na. Iscoe et al., TEMPORAL TRENDS IN BREAST-CANCER SURGERY IN ONTARIO - CAN ONE RANDOMIZED TRIAL MAKE A DIFFERENCE, CMAJ. Canadian Medical Association journal, 150(7), 1994, pp. 1109-1115
Citation: L. From et al., MIB-1 PROLIFERATIVE ACTIVIN IS A SIGNIFICANT PROGNOSTIC FACTOR IN PRIMARY THICK CUTANEOUS MALIGNANT MELANOMAS, Journal of investigative dermatology, 103(2), 1994, pp. 271-271